Outcome of pituitary hormone deficits after surgical treatment of nonfunctioning pituitary macroadenomas. 2021

Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. orsalia.alexopoulou@uclouvain.be.

Nonfunctionning pituitary macroadenomas (NFPMA) are benign tumors that cause symptoms of mass effects including hypopituitarism. Their primary treatment is transsphenoidal surgery. We aimed to determine the outcome of pituitary hormone deficits after surgical treatment of NFPMA and to identify factors predicting hormonal recovery. We retrospectively included 246 patients with NFPMA diagnosed and operated in one of the two participating centers. All hormonal axes were evaluated except growth hormone (GH). Postoperative improvement of pituitary endocrine function was considered if at least one hormonal deficit had recovered and a lower total number of deficits was observed 1 year after surgery. 80% (n = 197) of patients had one or more pituitary deficits and 28% had complete anterior hypopituitarism. Besides GH, the gonadotropic and thyrotropic axes were the most commonly affected (68% and 62%, respectively). The number of hypopituitary patients dropped significantly to 61% at 1 year (p < 0.001) and a significant improvement was observed for all hormonal axes, except central diabetes insipidus. Among patients with preoperative hypopituitarism, 88/175 (50%) showed improved pituitary function at 1 year. Both hyperprolactinemia at diagnosis and a lower tumor diameter independently predicted favorable endocrine outcome. Hypopituitarism is present in 80% of patients with NFPMA and nearly half of them will benefit from sustained improvement after surgery. Hyperprolactinaemia at diagnosis and lower tumor dimensions are associated with favorable endocrine prognosis. This supports the option of early surgery in NFPMA patients with pituitary deficits independent of the presence of visual disturbances.

UI MeSH Term Description Entries
D007018 Hypopituitarism Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions. Adenohypophyseal Hyposecretion,Anterior Pituitary Hyposecretion Syndrome,Sheehan Syndrome,Simmonds Disease,Hyposecretion Syndrome, Anterior Pituitary,Hyposecretion, Adenohypophyseal,Pituitary Insufficiency,Postpartum Hypopituitarism,Postpartum Panhypopituitarism,Postpartum Pituitary Insufficiency,Sheehan's Syndrome,Simmonds' Disease,Disease, Simmonds,Hypopituitarism, Postpartum,Insufficiency, Pituitary,Panhypopituitarism, Postpartum,Pituitary Insufficiency, Postpartum,Sheehans Syndrome,Simmond's Disease,Syndrome, Sheehan,Syndrome, Sheehan's
D010907 Pituitary Hormones Hormones secreted by the PITUITARY GLAND including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals (NEUROTRANSMITTERS) or neuroendocrine signals (HYPOTHALAMIC HORMONES) from the hypothalamus as well as feedback from their targets such as ADRENAL CORTEX HORMONES; ANDROGENS; ESTROGENS. Hormones, Pituitary
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
December 2023, Endocrine connections,
Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
January 2015, International journal of endocrinology,
Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
April 2013, Clinical endocrinology,
Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
April 2008, Nederlands tijdschrift voor geneeskunde,
Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
October 2008, The Journal of clinical endocrinology and metabolism,
Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
May 1995, The Journal of clinical endocrinology and metabolism,
Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
January 2020, Journal of neurosurgery,
Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
December 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
March 2007, Expert review of endocrinology & metabolism,
Orsalia Alexopoulou, and Valérie Everard, and Martine Etoa, and Edward Fomekong, and Stéphane Gaillard, and Fabrice Parker, and Christian Raftopoulos, and Philippe Chanson, and Dominique Maiter
March 2005, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!